Oaktree Fund Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Oaktree Fund Advisors, LLC

  • $77.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.24 - $2.33 $19,840 - $37,280
16,000 Added 32.0%
66,000 $132,000
Q4 2021

Feb 14, 2022
SELL
$4.65 - $7.23 $74,400 - $115,680
-16,000 Reduced 24.24%
50,000 $232,000
Q2 2021

Aug 16, 2021
BUY
$6.35 - $10.0 $419,100 - $660,000
66,000 New
66,000 $640,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Oaktree Fund Advisors, LLC Portfolio

Follow Oaktree Fund Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oaktree Fund Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oaktree Fund Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email